Impact of renal dysfunction on the diagnosis of acute pancreatitis using urinary trypsinogen‐2: A retrospective study

Abstract

AbstractAimEarly diagnosis of acute pancreatitis is crucial, and urinary trypsinogen has been recently reported as a useful biomarker for diagnosing acute pancreatitis. We aimed to evaluate the impact of renal dysfunction on the diagnostic performance of urinary trypsinogen‐2 for acute pancreatitis.MethodsWe conducted a retrospective study using the clinical data of patients who visited the Department of Emergency and Critical Care at the University of Tokyo Hospital between 1 October, 2021, and 30 June, 2022. Patients with available data on qualitative urinary trypsinogen‐2 levels were identified. We compared the urinary trypsinogen‐2 levels among patients who were clinically diagnosed with acute pancreatitis. We further stratified the patients according to renal function parameters, such as serum creatinine level, blood urea nitrogen level, and estimated glomerular filtration rate, and evaluated the performance of urinary trypsinogen‐2 as a biomarker for acute pancreatitis.ResultsWithin 9 months, 35 patients were identified. Of them, 22 patients showed positive results and 13 showed negative results on the urinary trypsinogen‐2 test. The sensitivity, specificity, positive predictive value, and negative predictive value were 0.80, 0.40, 0.18, and 0.92, respectively. Based on the blood urea nitrogen level and estimated glomerular filtration rate, the prevalence of false‐positive results was significantly higher in patients with reduced renal function than in those with normal renal function.ConclusionIn patients with reduced renal function, the urinary trypsinogen‐2 qualitative test results might be interpreted with caution when used for diagnosing acute pancreatitis.image